Skip to main content

Esposito Pamela's Form 4 filing

Kymera Therapeutics, Inc. (KYMR) · filed Jan 20, 2026

Accession no.
0001193125-26-016934
Filed
Jan 20, 2026
Trade date
Jan 20, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $373.5K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Esposito PamelaCIK 0001744425Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseAcquired+3,000$31.20+$93,6003,000Direct
Jan 20, 2026Common StockMOption exerciseAcquired+2,500$49.10+$122,7505,500Direct
Jan 20, 2026Common StockSSaleDisposed−400$66.68−$26,6725,100Direct
Jan 20, 2026Common StockSSaleDisposed−4,900$67.99−$333,151200Direct
Jan 20, 2026Common StockSSaleDisposed−200$68.52−$13,7040Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseDisposed−3,000$0.00$010,000Direct
Jan 20, 2026Common StockMOption exerciseDisposed−2,500$0.00$05,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)